Journal Information

Statistics

Follow this link to access the full text of the article

Research Letter
Treating hidradenitis suppurativa patients with adalimumab: a real-life experience of a tertiary care center in Lisboa, Portugal
José Miguel Neves
Corresponding author
josemoneves@gmail.com

Corresponding author.
, Nélia Cunha, André Lencastre, Joana Cabete
Department of Dermatology and Venereology, Hospital de Santo António dos Capuchos, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
Read
4480
Times
was read the article
1725
Total PDF
2755
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 55 27 82
2024 November 143 67 210
2024 October 113 56 169
2024 September 165 88 253
2024 August 145 109 254
2024 July 126 95 221
2024 June 116 70 186
2024 May 103 73 176
2024 April 130 107 237
2024 March 101 60 161
2024 February 123 89 212
2024 January 116 54 170
2023 December 90 66 156
2023 November 91 82 173
2023 October 97 78 175
2023 September 95 72 167
2023 August 54 36 90
2023 July 55 26 81
2023 June 54 33 87
2023 May 62 24 86
2023 April 36 19 55
2023 March 54 46 100
2023 February 56 48 104
2023 January 69 28 97
2022 December 86 44 130
2022 November 116 98 214
2022 October 254 81 335
2022 September 50 49 99
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.